Opentrons Labworks Inc. Overview
Pro stress-test →Opentrons Labworks is the current market leader in entry-level lab automation, accelerating innovation in research and healthcare through its integrated lab platform. Founded in 2014, the company manufactures liquid handling robots that use open-source software. Opentrons robots are deployed in thousands of academic, biopharma, synthetic biology and clinical research labs across more than 40 countries.
Strategic Profile
Pro stress-test →Opentrons is establishing itself as a leader in flexible lab automation with thousands of robots in labs worldwide, creating ongoing sales opportunities through recurring consumables, software upgrades, and service contracts. The company operates two business units: Opentrons Robotics, which provides flexible liquid handling lab robots used by thousands of institutions, and Neochromosome, which offers genome-scale cell engineering solutions for biopharma and biotech. Recent product launches like Flex Prep and Opentrons for Education showcase the company's focus on accessible, no-code robotic platforms for academic and research institutions.
Competitive Landscape
Pro stress-test →Opentrons is the current market leader in entry-level lab automation. The company competes against established laboratory automation vendors serving the life sciences sector. Competitors include larger industrial automation companies offering enterprise-grade solutions and specialized robotics firms targeting niche research workflows. Opentrons' differentiation centers on accessibility, open-source software, ease of use, and affordability relative to legacy incumbent solutions.
Industry Context
Opentrons Labworks Inc. operates in Lab automation robotics.
Key facts
Founded: 2014 · Headquarters: Long Island City, United States · Employees: 328 (as of 2023) · Revenue: Estimated $50M–$100M (as of 2023)